Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Sauer

Showing results (151-160 of 199) with videos related to

Pageof 20
Sort By:
Open Heart|March 25, 2021
Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panelChristopher F Spurney, Deborah Ascheim, Lawrence Charnas, et al.
Frontiers in Pediatrics|August 24, 2023
Effects of infection control measures towards preventing SARS-CoV-2 outbreaks in a German choir boarding school from March 2020 to April 2022Benedikt M J Lampl, Patricia Schöberl, Noah Atzenbeck, et al.
Clinical Pharmacology and Therapeutics|March 7, 2003
Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolitesStephan A Chalon, Jean-Pierre Desager, Karl A Desante, et al.
The Plant Journal : for Cell and Molecular Biology|September 9, 2008
ABCB19/PGP19 stabilises PIN1 in membrane microdomains in ArabidopsisBoosaree Titapiwatanakun, Joshua J Blakeslee, Anindita Bandyopadhyay, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 22, 2005
Simultaneous quantification of atomoxetine as well as its primary oxidative and O-glucuronide metabolites in human plasma and urine using liquid chromatography tandem mass spectrometry (LC/MS/MS)John H Mullen, Richard L Shugert, George D Ponsler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2002
Disposition and metabolic fate of atomoxetine hydrochloride: pharmacokinetics, metabolism, and excretion in the Fischer 344 rat and beagle dogEdward L Mattiuz, G Douglas Ponsler, Robert J Barbuch, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptorAmy C Porter, John-Michael Sauer, Michael D Knierman, et al.
The Plant Cell|June 18, 2013
MTV1 and MTV4 encode plant-specific ENTH and ARF GAP proteins that mediate clathrin-dependent trafficking of vacuolar cargo from the trans-Golgi networkMichael Sauer, M Otilia Delgadillo, Jan Zouhar, et al.
Inflammatory Bowel Diseases|August 26, 2020
Biomarkers of Crohn's Disease to Support the Development of New Therapeutic InterventionsAmy C Porter, Jiri Aubrecht, Chandler Birch, et al.
Current Biology : CB|May 31, 2011
A molecular switch for initiating cell differentiation in ArabidopsisMaite Sanmartín, Michael Sauer, Alfonso Muñoz, et al.
Pageof 20

Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
Open Heart|March 25, 2021
Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panelChristopher F Spurney, Deborah Ascheim, Lawrence Charnas, et al.
Frontiers in Pediatrics|August 24, 2023
Effects of infection control measures towards preventing SARS-CoV-2 outbreaks in a German choir boarding school from March 2020 to April 2022Benedikt M J Lampl, Patricia Schöberl, Noah Atzenbeck, et al.
Clinical Pharmacology and Therapeutics|March 7, 2003
Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolitesStephan A Chalon, Jean-Pierre Desager, Karl A Desante, et al.
The Plant Journal : for Cell and Molecular Biology|September 9, 2008
ABCB19/PGP19 stabilises PIN1 in membrane microdomains in ArabidopsisBoosaree Titapiwatanakun, Joshua J Blakeslee, Anindita Bandyopadhyay, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 22, 2005
Simultaneous quantification of atomoxetine as well as its primary oxidative and O-glucuronide metabolites in human plasma and urine using liquid chromatography tandem mass spectrometry (LC/MS/MS)John H Mullen, Richard L Shugert, George D Ponsler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2002
Disposition and metabolic fate of atomoxetine hydrochloride: pharmacokinetics, metabolism, and excretion in the Fischer 344 rat and beagle dogEdward L Mattiuz, G Douglas Ponsler, Robert J Barbuch, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptorAmy C Porter, John-Michael Sauer, Michael D Knierman, et al.
The Plant Cell|June 18, 2013
MTV1 and MTV4 encode plant-specific ENTH and ARF GAP proteins that mediate clathrin-dependent trafficking of vacuolar cargo from the trans-Golgi networkMichael Sauer, M Otilia Delgadillo, Jan Zouhar, et al.
Inflammatory Bowel Diseases|August 26, 2020
Biomarkers of Crohn's Disease to Support the Development of New Therapeutic InterventionsAmy C Porter, Jiri Aubrecht, Chandler Birch, et al.
Current Biology : CB|May 31, 2011
A molecular switch for initiating cell differentiation in ArabidopsisMaite Sanmartín, Michael Sauer, Alfonso Muñoz, et al.
Pageof 20